Risk adjusted net present value: What is the current valuation of Bavarian Nordic’s PXVX-0317?

PXVX-0317 is a subunit vaccine commercialized by Bavarian Nordic, with a leading Phase III program in Chikungunya Fever.

Pharmalittle: We’re reading about India-made versions of Wegovy, an RSV vaccine scramble, and more

Top of the morning to you, and a fine one it is. Clear blue skies are hovering over the Pharmalot campus, where a cool breeze

February 22, 2024

COVID-19 infection linked to increased risk of high blood pressure

An analysis of electronic medical records for more than 45,000 people found that COVID-19 infection was significantly associated with the development of high blood pressure,

August 21, 2023

MUSC Health Deploys AI to Automate Patient Self-Service Tasks

What You Should Know: – SoundHound AI, Inc. (Nasdaq: SOUN), a global leader in voice artificial intelligence, today announced that MUSC Health has deployed an

August 28, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.